Evidence map›Paper›PMID 40858846›Full record

ArticleScientific reports2025

Exploring the use of large language models for classification, clinical interpretation, and treatment recommendation in breast tumor patient records.

Beibei Miao, Qian Sun, Peien Wang, Rongjun Shao, Yingying Ding, Yuanlong Chen, Rongbiao Ying

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Beibei MiaoDepartment of Thyroid and Breast Surgery, Taizhou Campus of Zhejiang Cancer Hospital (Taizhou Cancer Hospital), No. 50, Zhenxin Road, Xinhe Town, Wenling, 317502, Taizhou, China.
Qian SunDepartment of Interventional and Minimally Invasive Surgery, Taizhou Campus of Zhejiang Cancer Hospital (Taizhou Cancer Hospital), No. 50, Zhenxin Road, Xinhe Town, Wenling, 317502, Taizhou, China.
Peien WangDepartment of Thyroid and Breast Surgery, Taizhou Campus of Zhejiang Cancer Hospital (Taizhou Cancer Hospital), No. 50, Zhenxin Road, Xinhe Town, Wenling, 317502, Taizhou, China.
Rongjun ShaoDepartment of Radiation Oncology, Taizhou Campus of Zhejiang Cancer Hospital (Taizhou Cancer Hospital), No. 50, Zhenxin Road, Xinhe Town, Wenling, 317502, Taizhou, China.
Yingying DingInternal Medicine Nursing, Taizhou Campus of Zhejiang Cancer Hospital (Taizhou Cancer Hospital), No. 50, Zhenxin Road, Xinhe Town, Wenling, 317502, Taizhou, China.
Yuanlong ChenDepartment of Thyroid and Breast Surgery, Taizhou Campus of Zhejiang Cancer Hospital (Taizhou Cancer Hospital), No. 50, Zhenxin Road, Xinhe Town, Wenling, 317502, Taizhou, China.
Rongbiao YingDepartment of Surgical Oncology, Taizhou Campus of Zhejiang Cancer Hospital (Taizhou Cancer Hospital), No. 50, Zhenxin Road, Xinhe Town, Wenling, 317502, Taizhou, China. yingrongbiao@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aims to investigate and compare the diagnostic performance, disease interpretation reliability, and treatment recommendation capabilities of multiple advanced large language models (GPT-4o, DeepSeek-R1, and DeepSeek-V3) in breast tumor cases. It retrospectively collected comprehensive clinical records of patients with breast tumors treated at Taizhou Cancer Hospital between January and April 2024. The study evaluated the accuracy of tumor classification (benign vs. malignant), the quality of disease interpretation, and the appropriateness of treatment recommendations generated by each model. To assess the clinical interpretability and utility of the models, a comprehensive performance analysis was conducted using statistical methods. A total of 45 patients with breast tumors were included, comprising 37 benign and 8 malignant cases (43 females, 2 males). GPT-4o achieved the highest area under the curve (AUC) for tumor classification (AUC = 0.848), outperforming DeepSeek-R1 (AUC = 0.736) and DeepSeek-V3 (AUC = 0.723). However, DeLong's test indicated that the differences in AUCs among the models were not statistically significant (p > 0.05). In addition, subjective evaluations by doctors indicated that DeepSeek-R1 received the highest scores for disease interpretation (4.73 ± 0.46) and treatment recommendations (4.70 ± 0.51), with consistent ratings.

Indexed as

Breast NeoplasmsAdultAgedFemaleHumansLarge Language ModelsMaleMiddle AgedReproducibility of ResultsRetrospective StudiesBreast tumorClinical dataDeepSeek-R1Large language models

Identifiers

PMID40858846
PMCPMC12381064

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.